155 related articles for article (PubMed ID: 22460028)
1. Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents.
Bacharaju K; Jambula SR; Sivan S; Jyostnatangeda S; Manga V
Bioorg Med Chem Lett; 2012 May; 22(9):3274-7. PubMed ID: 22460028
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating
Wu L; Yang Y; Wang Z; Wu X; Su F; Li M; Jing X; Han C
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150865
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.
Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL
Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.
Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2011 Jun; 21(12):3755-8. PubMed ID: 21555221
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and cytotoxicity of a new series of isoxazolidines derived from substituted chalcones.
Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE
Eur J Med Chem; 2011 Apr; 46(4):1382-9. PubMed ID: 21334117
[TBL] [Abstract][Full Text] [Related]
13. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
14. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents.
Hsieh CY; Ko PW; Chang YJ; Kapoor M; Liang YC; Lin HH; Horng JC; Hsu MH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31500191
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates.
Wang XJ; Xu HW; Guo LL; Zheng JX; Xu B; Guo X; Zheng CX; Liu HM
Bioorg Med Chem Lett; 2011 May; 21(10):3074-7. PubMed ID: 21486694
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors.
Li QS; Li CY; Lu X; Zhang H; Zhu HL
Eur J Med Chem; 2012 Apr; 50():288-95. PubMed ID: 22361686
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent.
Chhajed SS; Sonawane SS; Upasani CD; Kshirsagar SJ; Gupta PP
Comput Biol Chem; 2016 Apr; 61():138-44. PubMed ID: 26878127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
